Neuburgh Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Neuburgh Advisers's XBI Position: Q2 2019 in Review
Neuburgh Advisers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 22 shares — an estimated $2K sold.
Neuburgh Advisers first reported a position in XBI in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.
- Neuburgh Advisers reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
- Neuburgh Advisers sold 22 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $2K.
- Neuburgh Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 1 quarter.
- Neuburgh Advisers's State Street SPDR S&P Biotech ETF position peaked at $2K in Q1 2019.
- 424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.
Based on Neuburgh Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.